Recro Pharma, Inc. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | A | 7.99 | 171,184 | 1,367,760 | 171,184 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 7.99 | 1,425 | 11,386 | 214,384 | 215.8 K to 214.4 K (-0.66 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Buy | M | 0.00 | 5,000 | 0 | 215,809 | 210.8 K to 215.8 K (+2.37 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Grant | A | 0.00 | 35,801 | 0 | 210,809 | 175 K to 210.8 K (+20.46 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | M | 0.00 | 6,400 | 0 | 12,800 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Option Exercise | A | 7.99 | 60,592 | 484,130 | 60,592 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.99 | 1,782 | 14,238 | 44,063 | 45.8 K to 44.1 K (-3.89 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Buy | M | 0.00 | 6,400 | 0 | 45,845 | 39.4 K to 45.8 K (+16.23 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Grant | A | 0.00 | 12,672 | 0 | 39,445 | 26.8 K to 39.4 K (+47.33 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 7.99 | 53,859 | 430,333 | 53,859 | |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.99 | 1,880 | 15,021 | 28,155 | 30 K to 28.2 K (-6.26 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 5,750 | 0 | 30,035 | 24.3 K to 30 K (+23.68 %) |
| Jan 23 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 11,264 | 0 | 24,285 | 13 K to 24.3 K (+86.51 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Celano Michael | Chief Operating Off ... | Payment of Exercise | F | 7.41 | 1,702 | 12,612 | 26,773 | 28.5 K to 26.8 K (-5.98 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.41 | 979 | 7,254 | 13,021 | 14 K to 13 K (-6.99 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 7.41 | 4,223 | 31,292 | 175,008 | 179.2 K to 175 K (-2.36 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 7.41 | 4,223 | 31,292 | 175,008 | 179.2 K to 175 K (-2.36 %) |
| Jan 04 2019 | REPH | Recro Pharma, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 7.41 | 979 | 7,254 | 13,021 | 14 K to 13 K (-6.99 %) |